Приказ основних података о документу

dc.creatorKlisić, Aleksandra
dc.creatorKavarić, Nebojša
dc.creatorJovanović, Milovan
dc.creatorZvrko, Elvir
dc.creatorSkerović, Verica
dc.creatorŠćepanović, Anđelka
dc.creatorMedin, Darko
dc.creatorNinić, Ana
dc.date.accessioned2019-09-02T11:58:19Z
dc.date.available2019-09-02T11:58:19Z
dc.date.issued2017
dc.identifier.issn1735-1995
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2835
dc.description.abstractBackground: Recent studies hypothesize that dyslipidemia can predict glycated hemoglobin (HbA1c) and could be important contributing factor to the pathogenesis of type 2 diabetes mellitus (DM2). Therefore, we aimed to evaluate the influence of lipid parameters on long-term glycemic control in DM2. Materials and Methods: A total of 275 sedentary DM2 (mean [+/- standard deviation] age 60.6 [+/- 10.0] years) who volunteered to participate in this cross-sectional study were enrolled. Anthropometric (body weight, body hight, and waist circumference), biochemical parameters (fasting glucose, HbA1c, lipid parameters, creatinine), as well as blood pressure were obtained. Results: Total cholesterol (odds ratio [OR] = 1.30, 95% confidence interval [CI] [1.02-1.66], P = 0.032), triglycerides (OR = 1.34, 95% CI (1.07-1.67), P = 0.010), and low density lipoprotein cholesterol (OR = 1.42, 95% CI [1.10-1.83], P = 0.006) were the independent predictors of higher HBA1c, and as they increased by 1 mmol/L each, probabilities of higher HBA1c increased by 30%, 34%, and 42%, respectively. Low level of high-density lipoprotein cholesterol (HDL-c) was found to be the independent predictor of higher HBA1c (OR = 0.44, 95% CI [0.20-0.67], P = 0.039), and increase in HDL-c by 1 mmol/L, reduced the probability of higher HBA1c by 56%. Conclusion: Unfavorable lipid profile can predict HbA1c level in DM2 patients. Early diagnosis of dyslipidemia, as well as its monitoring and maintaining good lipids control can be used as a preventive measure for optimal long-term glycemic control.en
dc.publisherWolters Kluwer Medknow Publications, Mumbai
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS//
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.sourceJournal of Research in Medical Sciences
dc.subjectDiabetes mellitusen
dc.subjectdyslipidemiaen
dc.subjectglycated hemoglobinen
dc.subjectglycemic controlen
dc.titleAssociation between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitusen
dc.typearticle
dc.rights.licenseBY-NC-SA
dcterms.abstractШћепановић, Aнђелка; Зврко, Елвир; Клисић, Aлександра; Каварић, Небојша; Јовановић, Милован; Медин, Дарко; Нинић, Aна; Скеровић, Верица;
dc.citation.volume22
dc.citation.other22: -
dc.citation.rankM22
dc.identifier.wos000423018600003
dc.identifier.doi10.4103/jrms.JRMS_284_17
dc.identifier.pmid29259633
dc.identifier.scopus2-s2.0-85040723782
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/1467/2833.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу